International Nuclear Energy Act of 2025
Bill S 1801 establishes a pilot program for psilocybin-assisted therapy to help veterans and first responders combat PTSD, depression, and anxiety effectively.
Bill S 1801 establishes a pilot program for psilocybin-assisted therapy to help veterans and first responders combat PTSD, depression, and anxiety effectively.
Bill S 1801 aims to establish a pilot program that utilizes psilocybin-assisted therapy specifically for veterans and first responders. This initiative seeks to address mental health challenges faced by these groups, including PTSD, depression, and anxiety, by exploring the therapeutic potential of psilocybin, a naturally occurring psychedelic compound.
The primary intent of Bill S 1801 is to provide an innovative treatment option for veterans and first responders who may not have found relief through traditional mental health therapies. By creating a structured pilot program, the bill aims to gather data on the efficacy and safety of psilocybin-assisted therapy in treating mental health conditions prevalent among these populations.
Bill S 1801 represents a significant step towards exploring alternative therapies for mental health treatment among veterans and first responders. By establishing a pilot program for psilocybin-assisted therapy, the bill aims to provide valuable insights into its potential benefits and risks, ultimately contributing to improved mental health outcomes for these critical populations.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.